<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C745868C-1A14-451E-90DA-D92FDE99B4CA"><gtr:id>C745868C-1A14-451E-90DA-D92FDE99B4CA</gtr:id><gtr:name>University Cheikh Anta Diop de Dakar</gtr:name><gtr:address><gtr:line1>BP 5005</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C745868C-1A14-451E-90DA-D92FDE99B4CA"><gtr:id>C745868C-1A14-451E-90DA-D92FDE99B4CA</gtr:id><gtr:name>University Cheikh Anta Diop de Dakar</gtr:name><gtr:address><gtr:line1>BP 5005</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2F165730-D778-4994-9AF6-8223860C676A"><gtr:id>2F165730-D778-4994-9AF6-8223860C676A</gtr:id><gtr:firstName>Bouke</gtr:firstName><gtr:surname>de Jong</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190081982"><gtr:id>D31FEFBD-B06D-4E0D-87FA-D687C64FC6A7</gtr:id><gtr:title>Transmissibility of Mycobacterium africanum compared with the Cameroon strain of M tuberculosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190081982</gtr:grantReference><gtr:abstractText>Mycobacterium africanum causes up to half of TB in West Africa. It is closely related to regular M. tuberculosis, but we have identified some important differences. One of these is that a new diagnostic test does not perform well in people infected with M. africanum. This test is based on the protein ESAT-6, which is also used in a new generation TB vaccine. Another difference is that HIV infected people are even more susceptible to infection with M. africanum than with M. tuberculosis. Thirdly, people who were exposed to M. africanum are less likely to develop TB than those exposed to M. tuberculosis. Based on findings elsewhere, we suspect that the Cameroon strain, which has replaced M. africanum as the most important cause of TB in Cameroon, will be transmitted to other people more readily than M. africanum.||We continue the tests which identify the different bacteria which cause TB, including M. africanum and M. tuberculosis. We try to identify bacteria that spread more readily to contacts exposed to someone with TB. Ultimately we hope our findings may assist in optimization of diagnostic tests and in the control of the spread of tuberculosis.</gtr:abstractText><gtr:technicalSummary>Within the Tuberculosis Case contact (TBCC) study at MRC in the Gambia, we identified Mycobacterium africanum as an important cause of TB with 38% prevalence among smear positive TB patients. We identified several differences between M. africanum and M. tuberculosis sensu stricto, including an association with HIV infection, and a lower IFNg response among cases and contacts infected with M. africanum. ||The present study aims at clarifying further differences, by continued mycobacterial genotyping within the next Case Contact study, the Isoniazid Reversion Study (IRS). These include the hypothesis that the Cameroon strain, a subspecies of M. tuberculosis sensu stricto which in Cameroon appears to have replaced M. africanum over the last 30 years, is more readily transmissible than M. africanum. The Cameroon strain was found at low prevalence (3%) in the TBCC study, and continued genotyping of Case Contact isolates allows us to study this and other strains in more detail.||For genotyping, we use spoligotyping as well as PCR for strain defining Large Sequence Polymorphisms.||So far, 376 isolates of TB patients have been genotyped (both TBCC and IRS Case Contact studies), and these patients have in total 2495 household contacts. IRS isolates continue to include 38% M. africanum. We identified one group of isolates within M. tuberculosis sensu stricto which has only sporadically been identified elsewhere and may be named the Gambian family. When comparing tuberculin skin test positivity rates, as a measure of transmission, by strain for those strains with information on ? 100 contacts, we did not identify a significant difference between strains. However, the rate of primary progression within the 2 year follow-up differed between contacts of different strains, and was higher for contacts of Beijing family isolates and of strain RD174, and lower for contacts exposed to M. africanum. This fits with other findings on the Beijing and RD174 strains, which identified respectively a stronger immunosuppressive effect and a deletion in the DosR latency regulon.||In summary, this ongoing genotyping work has defined the molecular epidemiology of TB in the Gambia and highlighted the high prevalence of M. africanum in the region. Important phenotypic differences between M. africanum and M. tuberculosis, from the current and prior Case Contact Study, include an association with HIV infection and attenuated ESAT-6 immunogenicity. In addition, M. africanum infection appears to progress to disease at lower rates than M. tuberculosis. Genomic studies that aim to explain these differences may aid in our understanding of immunity to TB.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1001738</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dakar</gtr:collaboratingOrganisation><gtr:country>Senegal, Republic of</gtr:country><gtr:department>Centre Hospitalier Universitaire</gtr:department><gtr:description>WANETAM</gtr:description><gtr:id>92424A43-19FE-43E1-B99F-D69CA1F6A8B5</gtr:id><gtr:impact>Capacity building visits to partner institutions and trainings at the MRC Gambia unit</gtr:impact><gtr:outcomeId>daPmBnY2U2G-1</gtr:outcomeId><gtr:partnerContribution>Through the network we will genotype isolates from the region for drug resistance and phylogeny.</gtr:partnerContribution><gtr:piContribution>Together with Dr Martin Antonio we provide the TB trainings for 7 partner institutions as part of the West African Node of Excellence for TB, AIDS, malaria, funded in 2009 by EDCTP.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>237457</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH K01 award</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>EAA91A8E-CB56-496F-8C1D-518A182D59F8</gtr:id><gtr:outcomeId>48F094158AA0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The software automatically grids and classifies spoligotype results</gtr:description><gtr:id>2CAE9C16-EC5B-4EFE-BB53-206ACBCB275F</gtr:id><gtr:impact>publication PMID: 19674444</gtr:impact><gtr:outcomeId>GkPHHC2u4wj</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>spoligotype automated interpretation</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19674444</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CC4FCD7B-E38C-469E-98F2-137D8EDEA1ED</gtr:id><gtr:title>Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>PetBLCKnPUs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1C219EF-EB99-4F0A-A9B0-B9774C7F510E</gtr:id><gtr:title>Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c721e059d2551533a2a9aa5e0ffde77b"><gtr:id>c721e059d2551533a2a9aa5e0ffde77b</gtr:id><gtr:otherNames>Sutherland JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>TKBePQ1KkG1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9CF263E-40F6-48DF-B1F2-33D88A5FFBCD</gtr:id><gtr:title>Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87cefccd249f1cbbc1484acf7fcec2ce"><gtr:id>87cefccd249f1cbbc1484acf7fcec2ce</gtr:id><gtr:otherNames>Hill PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>hwBemvAGcRh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAD489B9-38E2-428D-83CC-C1AD4920C34F</gtr:id><gtr:title>Clinical presentation and outcome of tuberculosis patients infected by M. africanum versus M. tuberculosis.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>gD3k8poZ84t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D928FC57-A535-43DA-9D1C-8AEFA4D091CA</gtr:id><gtr:title>Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87cefccd249f1cbbc1484acf7fcec2ce"><gtr:id>87cefccd249f1cbbc1484acf7fcec2ce</gtr:id><gtr:otherNames>Hill PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>jEWwNo3yjpx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EE32723-3F31-4D2D-9D28-FF005063DAC3</gtr:id><gtr:title>Comparative evaluation of BACTEC MGIT 960 with BACTEC 9000 MB and LJ for isolation of mycobacteria in The Gambia.</gtr:title><gtr:parentPublicationTitle>Journal of infection in developing countries</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7bff8f060e6adc0a1448df422adddbf"><gtr:id>a7bff8f060e6adc0a1448df422adddbf</gtr:id><gtr:otherNames>Otu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1972-2680</gtr:issn><gtr:outcomeId>VEakEyDcR2x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EAE599C-6B89-4867-B747-C93ADFD3FA3A</gtr:id><gtr:title>The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed467b9b110c9f187ed7663f41ed5a07"><gtr:id>ed467b9b110c9f187ed7663f41ed5a07</gtr:id><gtr:otherNames>Bentley SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_15731_21_22389744</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EAA346E-2724-4F07-A246-8C0CB6A70162</gtr:id><gtr:title>Supervised learning for the automated transcription of spacer classification from spoligotype films.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cce2128624262c905a1c0eca64edc701"><gtr:id>cce2128624262c905a1c0eca64edc701</gtr:id><gtr:otherNames>Jeffries DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>YqDM6W6H3a2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A840EE1-D128-4748-A071-3456C26D6537</gtr:id><gtr:title>Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>kJbJyVgk32f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FB3DBCC-30D4-4051-AA71-10DBE8095242</gtr:id><gtr:title>Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>kmhmtzjK9Ws</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C8F031A-C93D-460B-BBB6-F01257745A64</gtr:id><gtr:title>Immunogenicity of antigens from the TbD1 region present in M. africanum and missing from &amp;quot;modern&amp;quot; M. tuberculosis: a cross- sectional study.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>oJRcygBepAM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36BBE82B-4091-443F-8507-D5BA7B90E2EE</gtr:id><gtr:title>Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87cefccd249f1cbbc1484acf7fcec2ce"><gtr:id>87cefccd249f1cbbc1484acf7fcec2ce</gtr:id><gtr:otherNames>Hill PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>JXeWJ3V8KNf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1F2DA81-95DD-4D84-8BA7-D64870094BAB</gtr:id><gtr:title>Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>hxgMxKzcxPy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>094248E5-C447-4912-B59E-CFB2B242F0D8</gtr:id><gtr:title>Rising ELISPOT count prior to the onset of symptoms of full-blown tuberculosis disease.</gtr:title><gtr:parentPublicationTitle>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54e75f29ffc79c9257e04566c7c6017c"><gtr:id>54e75f29ffc79c9257e04566c7c6017c</gtr:id><gtr:otherNames>Adetifa IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1027-3719</gtr:issn><gtr:outcomeId>TjgidzFt6EA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2498EC73-F848-4879-B371-B23B1C6FA7A7</gtr:id><gtr:title>Differences between tuberculosis cases infected with Mycobacterium africanum, West African type 2, relative to Euro-American Mycobacterium tuberculosis: an update.</gtr:title><gtr:parentPublicationTitle>FEMS immunology and medical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32e2c5e83ca8d1853991693161a6184d"><gtr:id>32e2c5e83ca8d1853991693161a6184d</gtr:id><gtr:otherNames>de Jong BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0928-8244</gtr:issn><gtr:outcomeId>tiK1FBDfcXu</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190081982</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>